|

Longitudinal Registry Including Patients Treated With Heavy Particles

RECRUITINGSponsored by CNAO National Center of Oncological Hadrontherapy
Actively Recruiting
SponsorCNAO National Center of Oncological Hadrontherapy
Started2021-06-04
Est. completion2030-06-04
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05203250

Summary

The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia. By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients treated with heavy particles at Fondazione CNAO, Pavia
* Patients who have the ability to understand and be willing to sign a written informed consent document

Exclusion Criteria:

* Patients or legal guardians who are unable to understand informed consent document

Conditions6

CancerOncologyRadiation ExposureRadiation ToxicityRadiotherapy Side EffectRare Disease

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.